FBRX
Forte Biosciences, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Forte Biosciences, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Largest filed tie
0
filed ties
No changes.
No changes.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
No thesis.
Annual filing, covered
10-K parsed · Mar 31 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 31 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
—
Forte Biosciences, Inc.
77.01
Tall tick = annual report · Source: EDGAR
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for Forte Biosciences, Inc..
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for Forte Biosciences, Inc..
| Manager | Value | % base | |
|---|---|---|---|
| Federated Investors | $44.8M | 10.31% | +19.54% |
| Orbimed | $33.5M | 7.71% | +31.81% |
| Fred Alger | $30.6M | 7.04% | +13.01% |
| Jupiter Topco | $29.2M | 6.72% | — |
| BlackRockindex-like | $26.0M | 5.98% | +1755.04% |
| Manager | Value | % base | |
|---|---|---|---|
| Federated Investors | $44.8M | 10.31% | +19.54% |
| Orbimed | $33.5M | 7.71% | +31.81% |
| Fred Alger | $30.6M | 7.04% | +13.01% |
| Jupiter Topco | $29.2M | 6.72% | — |
| BlackRockindex-like | $26.0M | 5.98% | +1755.04% |
Bull2
Bear1
Expected move
No implied move.